Roche (SWX: RO, ROG) announced today that it is partnering with Diabeloop to advance insulin pump therapy management.
Basel, Switzerland-based Roche said in a news release that the partnership will create new opportunities to lower the burden of constant insulin dose adjustment for those with diabetes while also improving therapy outcomes.
Get the full story at our sister site, Drug Delivery Business News.